FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1484963749> ?p ?o ?g. }

• W1484963749 endingPage "371" @default.
• W1484963749 startingPage "367" @default.
• W1484963749 abstract "Sodium-glucose cotransporters 1 (SGLT1) and 2 (SGLT2) are the major cellular transporters responsible for gastrointestinal (GI) glucose absorption and renal glucose reabsorption, respectively. LX4211, a dual inhibitor of SGLT1 and SGLT2, reduces glucose absorption from the GI tract and enhances urinary glucose excretion. Although several SGLT2-selective inhibitors have been tested in large phase 2 studies, dual inhibition of SGLT1 and SGLT2 is novel at this stage of drug development, and it has implications for clinical-trial design. In this article, we describe the design and rationale of a phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of LX4211 in subjects with type 2 diabetes mellitus who have inadequate glycemic control on metformin monotherapy. The primary endpoint is the change in glycated hemoglobin A1c from baseline to week 12. Secondary endpoints include the proportion of subjects achieving a glycated hemoglobin A1c value of <7%, change from baseline in fasting plasma glucose and postprandial glucose (as part of an oral glucose tolerance test), body weight, and blood pressure. Safety is evaluated with particular focus on hypoglycemia, GI symptoms, and incidence of genitourinary tract infections." @default.
• W1484963749 created "2016-06-24" @default.
• W1484963749 creator A5006568353 @default.
• W1484963749 creator A5008668315 @default.
• W1484963749 creator A5036567628 @default.
• W1484963749 creator A5040261977 @default.
• W1484963749 creator A5041036914 @default.
• W1484963749 creator A5045489578 @default.
• W1484963749 creator A5048662979 @default.
• W1484963749 creator A5050005771 @default.
• W1484963749 creator A5068326733 @default.
• W1484963749 creator A5075068326 @default.
• W1484963749 creator A5080960032 @default.
• W1484963749 date "2013-04-29" @default.
• W1484963749 modified "2023-10-14" @default.
• W1484963749 title "Study Design and Rationale of a Dose-Ranging Trial of LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy" @default.
• W1484963749 cites W2036834667 @default.
• W1484963749 cites W2051729661 @default.
• W1484963749 cites W2052976889 @default.
• W1484963749 cites W2058969403 @default.
• W1484963749 cites W2063643017 @default.
• W1484963749 cites W2082515526 @default.
• W1484963749 cites W2084948079 @default.
• W1484963749 cites W2088731447 @default.
• W1484963749 cites W2091685843 @default.
• W1484963749 cites W2119843247 @default.
• W1484963749 cites W2133469996 @default.
• W1484963749 cites W2167245776 @default.
• W1484963749 cites W2171183320 @default.
• W1484963749 doi "https://doi.org/10.1002/clc.22125" @default.
• W1484963749 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6649411" @default.
• W1484963749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23630033" @default.
• W1484963749 hasPublicationYear "2013" @default.
• W1484963749 type Work @default.
• W1484963749 sameAs 1484963749 @default.
• W1484963749 citedByCount "13" @default.
• W1484963749 countsByYear W14849637492014 @default.
• W1484963749 countsByYear W14849637492015 @default.
• W1484963749 countsByYear W14849637492016 @default.
• W1484963749 countsByYear W14849637492019 @default.
• W1484963749 countsByYear W14849637492021 @default.
• W1484963749 countsByYear W14849637492022 @default.
• W1484963749 countsByYear W14849637492023 @default.
• W1484963749 crossrefType "journal-article" @default.
• W1484963749 hasAuthorship W1484963749A5006568353 @default.
• W1484963749 hasAuthorship W1484963749A5008668315 @default.
• W1484963749 hasAuthorship W1484963749A5036567628 @default.
• W1484963749 hasAuthorship W1484963749A5040261977 @default.
• W1484963749 hasAuthorship W1484963749A5041036914 @default.
• W1484963749 hasAuthorship W1484963749A5045489578 @default.
• W1484963749 hasAuthorship W1484963749A5048662979 @default.
• W1484963749 hasAuthorship W1484963749A5050005771 @default.
• W1484963749 hasAuthorship W1484963749A5068326733 @default.
• W1484963749 hasAuthorship W1484963749A5075068326 @default.
• W1484963749 hasAuthorship W1484963749A5080960032 @default.
• W1484963749 hasBestOaLocation W14849637491 @default.
• W1484963749 hasConcept C126322002 @default.
• W1484963749 hasConcept C134018914 @default.
• W1484963749 hasConcept C142724271 @default.
• W1484963749 hasConcept C168563851 @default.
• W1484963749 hasConcept C203092338 @default.
• W1484963749 hasConcept C204787440 @default.
• W1484963749 hasConcept C27081682 @default.
• W1484963749 hasConcept C2777180221 @default.
• W1484963749 hasConcept C2777538456 @default.
• W1484963749 hasConcept C2778199505 @default.
• W1484963749 hasConcept C2780323712 @default.
• W1484963749 hasConcept C2780473172 @default.
• W1484963749 hasConcept C2780668416 @default.
• W1484963749 hasConcept C2910068830 @default.
• W1484963749 hasConcept C555293320 @default.
• W1484963749 hasConcept C71924100 @default.
• W1484963749 hasConcept C90466245 @default.
• W1484963749 hasConcept C90924648 @default.
• W1484963749 hasConcept C98274493 @default.
• W1484963749 hasConceptScore W1484963749C126322002 @default.
• W1484963749 hasConceptScore W1484963749C134018914 @default.
• W1484963749 hasConceptScore W1484963749C142724271 @default.
• W1484963749 hasConceptScore W1484963749C168563851 @default.
• W1484963749 hasConceptScore W1484963749C203092338 @default.
• W1484963749 hasConceptScore W1484963749C204787440 @default.
• W1484963749 hasConceptScore W1484963749C27081682 @default.
• W1484963749 hasConceptScore W1484963749C2777180221 @default.
• W1484963749 hasConceptScore W1484963749C2777538456 @default.
• W1484963749 hasConceptScore W1484963749C2778199505 @default.
• W1484963749 hasConceptScore W1484963749C2780323712 @default.
• W1484963749 hasConceptScore W1484963749C2780473172 @default.
• W1484963749 hasConceptScore W1484963749C2780668416 @default.
• W1484963749 hasConceptScore W1484963749C2910068830 @default.
• W1484963749 hasConceptScore W1484963749C555293320 @default.
• W1484963749 hasConceptScore W1484963749C71924100 @default.
• W1484963749 hasConceptScore W1484963749C90466245 @default.
• W1484963749 hasConceptScore W1484963749C90924648 @default.
• W1484963749 hasConceptScore W1484963749C98274493 @default.
• W1484963749 hasIssue "7" @default.
• W1484963749 hasLocation W14849637491 @default.
• W1484963749 hasLocation W14849637492 @default.
• W1484963749 hasLocation W14849637493 @default.

• next